Companies: 10,795·Total market cap: $144.5T
Elixxer Ltd.

Elixxer Ltd.

ELIXFOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$23349740
P/E Ratio
52W High$0.0991
52W Low$0.0013
Overview

Elixxer Ltd.(ELIXF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ELIXF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.34elixf eps ttm · elixf earnings per shareEarnings history
PE Ratio (TTM)elixf pe ratio ttm · elixf price to earningsPE Ratio deep dive
Revenue (TTM)0.00elixf revenue ttm · elixf annual revenueFull revenue history
Dividend Yield不分红does elixf pay dividends · elixf dividend yieldDividend history
Shares Outstanding11.3Melixf shares outstanding · elixf floatShares outstanding history
Next EarningsTBAelixf earnings date · elixf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
elixxer ltd. revenue · elixf revenue 2025
FY 2025Net Income-$3.9M▼ 111460.32% YoY
202320242025
elixxer ltd. net income · elixf profit 2025
FY 2025EPS$-0.34▼ 84900.00% YoY
202320242025
elixf eps · elixxer ltd. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$3.9MEPS: $-0.34View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+199.11%
1Y+449.18%
5Y-100.00%

关于 Elixxer Ltd.

CEOKarim Mecklai
IPO DateDec 14, 2017
Employees
CountryCA

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, product…

what is elixxer ltd. · elixf stock overview · elixxer ltd. company profile · who is elixxer ltd. ceo · elixf OTC · elixxer ltd. headquarters · elixxer ltd. business segments

关于股票概览与关键数据

Elixxer Ltd.(ELIXF)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Dec 14, 2017 在 OTC 上市。截至最近交易日,ELIXF 股价为 $0.03,市值约为 $23.3M。过去12个月累计回报 +449.18%,年初至今回报 +199.11%。

2025 财年 Elixxer Ltd. 营收 —。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Elixxer Ltd.(ELIXF)股价为 $0.03,在 OTC 上市,52周区间为 $0.00 – $0.10。

ELIXF 最新股价ELIXF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议